InMode Appoints Michael Dennison as President of North America
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 03 2025
0mins
Should l Buy INMD?
Source: PRnewswire
Leadership Appointment: InMode Ltd. has appointed Michael Dennison as President of North America, promoting him from his previous role as Vice President of Sales.
Experience and Achievements: Dennison has nearly a decade of leadership experience at InMode and has a strong background in the aesthetic medical device industry, having previously held various sales positions and consistently exceeded targets.
Strategic Vision: CEO Moshe Mizrahy emphasized Dennison's commitment to talent development and market excellence, highlighting his role in advancing InMode's strategic initiatives and growth in North America.
Company Overview: InMode is a global provider of innovative medical technologies, specializing in devices that utilize radiofrequency technology for various medical fields, including plastic surgery and dermatology.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy INMD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on INMD
Wall Street analysts forecast INMD stock price to rise
5 Analyst Rating
1 Buy
4 Hold
0 Sell
Hold
Current: 13.700
Low
15.00
Averages
17.33
High
21.00
Current: 13.700
Low
15.00
Averages
17.33
High
21.00
About INMD
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
InMode to Present at 25th Annual Needham Virtual Healthcare Conference
- Conference Details: InMode Ltd.'s CEO Moshe Mizrahy and CFO Yair Malca will present at the 25th Annual Needham Virtual Healthcare Conference on April 13, 2026, showcasing the company's innovations in medical technology.
- Investor Engagement: The event will feature virtual one-on-one meetings with investors, allowing for enhanced interaction and transparency by enabling investors to schedule meetings through their Needham representatives.
- Technological Focus: InMode specializes in developing and marketing devices that utilize novel radiofrequency technology across various fields, including plastic surgery, gynecology, and dermatology, aiming to drive new surgical procedures and improve existing treatments.
- Forward-Looking Statements: The company cautions that actual financial or operational performance may differ from expectations, urging investors to consider risk factors and cautionary statements to avoid undue reliance on forward-looking statements.
See More
InMode to Present at 25th Annual Needham Virtual Healthcare Conference
- Conference Details: InMode's CEO Moshe Mizrahy and CFO Yair Malca will present at the 25th Annual Needham Virtual Healthcare Conference on April 13, 2026, showcasing the company's latest medical technologies and market strategies, which is expected to attract investor interest.
- Investor Engagement: On the same day, InMode will also hold virtual one-on-one investor meetings, providing opportunities for direct interaction with company executives, aimed at enhancing investor relations and fostering potential investment collaborations.
- Technological Innovation: InMode focuses on developing and manufacturing innovative medical devices that leverage novel radiofrequency technology, committed to enabling emerging surgical procedures and improving existing treatments, demonstrating the company's leadership in the medical technology sector.
- Forward-Looking Statements: The press release includes forward-looking statements regarding the company's future financial and operational performance, cautioning investors about potential risks and uncertainties to better assess their investment decisions.
See More
InMode Authorizes 10% Share Buyback Program
- Share Buyback Program: InMode's Board has authorized a new share repurchase program for up to 10% of its outstanding shares, approximately 6.38 million shares, reflecting the company's commitment to returning value to shareholders despite challenging economic conditions.
- Strong Cash Flow: Despite macroeconomic challenges, InMode continues to generate robust cash flow, with management believing that repurchasing shares at current valuations is an attractive use of capital aimed at enhancing shareholder value.
- Price Trend Analysis: Currently, InMode's stock is trading 7.4% below its 50-day simple moving average and 8% below its 200-day moving average, with a 30.88% decline over the past 12 months, indicating market caution regarding its future performance.
- Financial Expectations: InMode is expected to report earnings of $0.37 per share and revenue of $79.32 million in its upcoming financial update on April 27, 2026, showing year-over-year growth, although analysts maintain a hold rating with price targets ranging from $15 to $25.
See More
InMode Board Approves New Share Repurchase Program
- Repurchase Program Authorization: InMode's board has approved a new share repurchase program allowing for the buyback of approximately 10% of its outstanding shares, equating to around 6.38 million shares, reflecting the company's confidence in its value and aiming to enhance shareholder returns.
- Funding Source Clarified: The company plans to fund the repurchases with available cash, indicating a robust financial position that allows for stock buybacks without impacting operations, thereby boosting market confidence in its future growth.
- Historical Buyback Performance: In 2025, the company repurchased approximately $127.4 million of its outstanding shares through buyback programs, demonstrating its ongoing capital management strategy and commitment to shareholder value, which further solidifies investor trust.
- Positive Stock Price Reaction: InMode's shares rose by 4.9% to $13.39, indicating a favorable market reaction to the repurchase program, which may attract more investor attention and enhance the company's market performance.
See More
InMode Announces New Share Repurchase Program
- Repurchase Program Authorization: InMode's Board of Directors has authorized a new share repurchase program for approximately 6.38 million shares, representing about 10% of total outstanding shares, reflecting the company's confidence in its current valuation.
- Strong Cash Flow: Despite challenging macroeconomic conditions, InMode repurchased approximately $127.4 million of its ordinary shares in 2025, indicating its ability to generate strong cash flow and effectively utilize capital.
- Capital Allocation Strategy: Management remains focused on navigating ongoing regional conflicts while maintaining a disciplined approach to capital allocation, with plans to evaluate additional repurchase programs and other capital allocation opportunities to enhance shareholder value.
- Market Condition Flexibility: Repurchases will be funded with available cash and may occur in the open market or through other permitted means, depending on market conditions, demonstrating the company's flexibility and adaptability in capital operations.
See More
InMode Announces New Share Repurchase Program
- Repurchase Program Authorization: InMode's Board of Directors has authorized a new share repurchase program allowing for the buyback of up to approximately 10% of its outstanding shares, equating to about 6.38 million shares, reflecting the company's confidence in its current valuation and expected to enhance shareholder value.
- Strong Cash Flow: Despite facing macroeconomic challenges, InMode repurchased approximately $127.4 million of its ordinary shares in 2025 through repurchase programs, indicating the company's ability to generate strong cash flow and effectively utilize capital.
- Capital Allocation Strategy: Management remains focused on navigating ongoing regional conflicts while maintaining a disciplined approach to capital allocation, with plans to continue evaluating additional repurchase programs and other capital allocation opportunities to optimize resource use.
- Market Condition Flexibility: The repurchase program will be funded with available cash, and repurchases may occur in the open market or through other permitted means, depending on market conditions, demonstrating the company's flexibility and adaptability in capital operations.
See More
InMode to Present at 25th Annual Needham Virtual Healthcare Conference
- Conference Details: InMode Ltd.'s CEO Moshe Mizrahy and CFO Yair Malca will present at the 25th Annual Needham Virtual Healthcare Conference on April 13, 2026, showcasing the company's innovations in medical technology.
- Investor Engagement: The event will feature virtual one-on-one meetings with investors, allowing for enhanced interaction and transparency by enabling investors to schedule meetings through their Needham representatives.
- Technological Focus: InMode specializes in developing and marketing devices that utilize novel radiofrequency technology across various fields, including plastic surgery, gynecology, and dermatology, aiming to drive new surgical procedures and improve existing treatments.
- Forward-Looking Statements: The company cautions that actual financial or operational performance may differ from expectations, urging investors to consider risk factors and cautionary statements to avoid undue reliance on forward-looking statements.
See More
InMode to Present at 25th Annual Needham Virtual Healthcare Conference
- Conference Details: InMode's CEO Moshe Mizrahy and CFO Yair Malca will present at the 25th Annual Needham Virtual Healthcare Conference on April 13, 2026, showcasing the company's latest medical technologies and market strategies, which is expected to attract investor interest.
- Investor Engagement: On the same day, InMode will also hold virtual one-on-one investor meetings, providing opportunities for direct interaction with company executives, aimed at enhancing investor relations and fostering potential investment collaborations.
- Technological Innovation: InMode focuses on developing and manufacturing innovative medical devices that leverage novel radiofrequency technology, committed to enabling emerging surgical procedures and improving existing treatments, demonstrating the company's leadership in the medical technology sector.
- Forward-Looking Statements: The press release includes forward-looking statements regarding the company's future financial and operational performance, cautioning investors about potential risks and uncertainties to better assess their investment decisions.
See More
InMode Authorizes 10% Share Buyback Program
- Share Buyback Program: InMode's Board has authorized a new share repurchase program for up to 10% of its outstanding shares, approximately 6.38 million shares, reflecting the company's commitment to returning value to shareholders despite challenging economic conditions.
- Strong Cash Flow: Despite macroeconomic challenges, InMode continues to generate robust cash flow, with management believing that repurchasing shares at current valuations is an attractive use of capital aimed at enhancing shareholder value.
- Price Trend Analysis: Currently, InMode's stock is trading 7.4% below its 50-day simple moving average and 8% below its 200-day moving average, with a 30.88% decline over the past 12 months, indicating market caution regarding its future performance.
- Financial Expectations: InMode is expected to report earnings of $0.37 per share and revenue of $79.32 million in its upcoming financial update on April 27, 2026, showing year-over-year growth, although analysts maintain a hold rating with price targets ranging from $15 to $25.
See More
InMode Board Approves New Share Repurchase Program
- Repurchase Program Authorization: InMode's board has approved a new share repurchase program allowing for the buyback of approximately 10% of its outstanding shares, equating to around 6.38 million shares, reflecting the company's confidence in its value and aiming to enhance shareholder returns.
- Funding Source Clarified: The company plans to fund the repurchases with available cash, indicating a robust financial position that allows for stock buybacks without impacting operations, thereby boosting market confidence in its future growth.
- Historical Buyback Performance: In 2025, the company repurchased approximately $127.4 million of its outstanding shares through buyback programs, demonstrating its ongoing capital management strategy and commitment to shareholder value, which further solidifies investor trust.
- Positive Stock Price Reaction: InMode's shares rose by 4.9% to $13.39, indicating a favorable market reaction to the repurchase program, which may attract more investor attention and enhance the company's market performance.
See More
InMode Announces New Share Repurchase Program
- Repurchase Program Authorization: InMode's Board of Directors has authorized a new share repurchase program for approximately 6.38 million shares, representing about 10% of total outstanding shares, reflecting the company's confidence in its current valuation.
- Strong Cash Flow: Despite challenging macroeconomic conditions, InMode repurchased approximately $127.4 million of its ordinary shares in 2025, indicating its ability to generate strong cash flow and effectively utilize capital.
- Capital Allocation Strategy: Management remains focused on navigating ongoing regional conflicts while maintaining a disciplined approach to capital allocation, with plans to evaluate additional repurchase programs and other capital allocation opportunities to enhance shareholder value.
- Market Condition Flexibility: Repurchases will be funded with available cash and may occur in the open market or through other permitted means, depending on market conditions, demonstrating the company's flexibility and adaptability in capital operations.
See More
InMode Announces New Share Repurchase Program
- Repurchase Program Authorization: InMode's Board of Directors has authorized a new share repurchase program allowing for the buyback of up to approximately 10% of its outstanding shares, equating to about 6.38 million shares, reflecting the company's confidence in its current valuation and expected to enhance shareholder value.
- Strong Cash Flow: Despite facing macroeconomic challenges, InMode repurchased approximately $127.4 million of its ordinary shares in 2025 through repurchase programs, indicating the company's ability to generate strong cash flow and effectively utilize capital.
- Capital Allocation Strategy: Management remains focused on navigating ongoing regional conflicts while maintaining a disciplined approach to capital allocation, with plans to continue evaluating additional repurchase programs and other capital allocation opportunities to optimize resource use.
- Market Condition Flexibility: The repurchase program will be funded with available cash, and repurchases may occur in the open market or through other permitted means, depending on market conditions, demonstrating the company's flexibility and adaptability in capital operations.
See More
